Biostatistics primer: What a clinician ought to know-prognostic and predictive factors

Journal of Thoracic Oncology

Volumn 8, Issue 6, 2013, Pages 808-813

  Simms, Lorinda ^a   Barraclough, Helen ^b   Govindan, Ramaswamy ^c,d  

^a ELI LILLY AND COMPANY   (United States)

^b ELI LILLY AUSTRALIA PTY LTD   (Australia)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Washington University in St Louis School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ADVANCED CANCER; AGE; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; COMPARATIVE STUDY; ETHNICITY; HUMAN; MEDICAL RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX; SEX DIFFERENCE; SMOKING; SURVIVAL RATE;

EID: 84879465616     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318292bdcd     Document Type: Article

References (11)

1. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991;266:93-98.
2. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med 1992;116:78-84.
3. Bulpitt CJ. Subgroup analysis. Lancet 1988;2:31-34.
4. National Cancer Institute Dictionary of Cancer Terms. Definition of prognostic factor. Available at: http://www.cancer.gov/ dictionary?cdrid=44246. Accessed November 16, 2012.
5. National Cancer Institute Dictionary of Cancer Terms. Definition of predictive factor. Available at: http://www.cancer.gov/dictionary?CdrID=44245. Accessed November 16, 2012.
6. Sterne JA, Davey Smith G. Sifting the evidence-what's wrong with significance tests? BMJ 2001;322:226-231. (Pubitemid 32116172)
7. International Conference on Harmonization (ICH) Topic E9. Statistical principles for clinical trials, 1998.
8. Barraclough H, Govindan R. Biostatistics primer: what a clinician ought to know: subgroup analyses. J Thorac Oncol 2010;5:741-746.
9. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355:1064-1069. (Pubitemid 30162810)
10. Pocock SJ, Hughes MD. Estimation issues in clinical trials and overviews. Stat Med 1990;9:657-671. (Pubitemid 20235038)
11. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987;317:426-432. (Pubitemid 17131180)